National Research Q3 revenue up 13% to $37.8M; EPS $0.38 vs $0.37

NRC HEALTH

2021-Q3 EPS reported $1.08 revenue$109,656,000

Revenue $37.8M (+13% YoY); operating income $13.1M (+9%).
Recurring Contract Value $151.5M; Voice of Customer revenue up 20%.
Net income $9.7M vs $9.6M; diluted EPS $0.38 vs $0.37.
Cash balance $52.5M; new clients Sharp Healthcare and UConn Health.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.